Biomarker analysis demonstrated that the carcinoma was estrogen receptor (ER) positive (strong positivity in 90% of tumor cells); progesterone receptor (PR) negative (complete absence of expression); and demonstrated lack of overexpression of human epidermal growth factor receptor type 2 (HERCEPTEST 1+). The gene discussed is ESR1; the disease is neoplasm.